Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference26 articles.
1. Iron-chelating therapy and the treatment of thalassemia;Olivieri;Blood,1997
2. Evaluation of a new method of administration of the iron chelating agent deferoxamine;Borgna-Pignatti;J Pediatr,1997
3. Desferrioxamine ototoxicity: evaluation of risk factors in thalassemic patients and guidelines for safe dosage;Porter;Br J Haematol,1989
4. Ocular toxicity of high-dose intravenous desferrioxamine;Davies;Lancet,1983
5. Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusions;Olivieri;N Engl J Med,1986
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals with β‐thalassemia major;World Journal of Otorhinolaryngology - Head and Neck Surgery;2023-12-10
2. Effects on hearing after long-term use of iron chelators in beta-thalassemia: Over twenty years of longitudinal follow-up;Auris Nasus Larynx;2023-10
3. Hearing Loss in Beta-Thalassemia: Systematic Review;Journal of Clinical Medicine;2021-12-25
4. Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model;Frontiers in Neurology;2021-03-24
5. Olfactory Dysfunction in β Thalassemia Major Patients Treated With Iron-Chelating Agents;Ear, Nose & Throat Journal;2019-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3